Munich - Delayed Quote EUR
Viking Therapeutics Inc (1VT.MU)
22.46
+0.09
+(0.42%)
As of 8:08:07 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-87,790
-87,790
-73,376
-48,397
-47,586
Investing Cash Flow
-553,366
-553,366
-179,086
54,753
37,960
Financing Cash Flow
612,464
612,464
271,376
4,163
6,880
End Cash Position
26,676
26,676
55,516
36,632
26,371
Issuance of Capital Stock
597,094
597,094
269,760
--
--
Repurchase of Capital Stock
--
--
--
-6,817
--
Free Cash Flow
-87,790
-87,790
-73,376
-48,397
-47,586
12/31/2021 - 4/10/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
603233.SS DaShenLin Pharmaceutical Group Co., Ltd.
17.46
+0.34%
1OT.F Ovid Therapeutics Inc.
0.2260
+15.31%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
MBX MBX Biosciences, Inc.
8.99
+4.05%
DSGN Design Therapeutics, Inc.
4.0700
+2.78%
SEPN Septerna, Inc.
6.14
+2.85%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%